Apyx Medical (APYX) Market Capitalization (2010 - 2026)

Apyx Medical (APYX) has reported Market Capitalization for 17 consecutive years, with $189.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization rose 122.38% year-over-year to $189.1 million; the trailing twelve-month figure through Jun 2026 stood at $189.1 million (up 122.38% YoY), and the FY2025 full-year result was $146.3 million, up 144.92% from the prior year.
• Market Capitalization climbed to $189.1 million in Q2 2026 per APYX's latest filing, from $154.5 million in the prior quarter.
• Across five years, Market Capitalization topped out at $225.0 million in Q1 2022 and bottomed at $43.0 million in Q3 2024.
• Historically, Market Capitalization has averaged $113.5 million across 5 years, with a median of $95.2 million in 2023.
• The sharpest annual moves came in 2022 and 2026: Market Capitalization slumped 81.65% in 2022, then surged 198.38% in 2026.
• Over 5 years, Market Capitalization stood at $81.0 million in 2022, then increased by 12.11% to $90.8 million in 2023, then tumbled by 34.21% to $59.7 million in 2024, then surged by 144.92% to $146.3 million in 2025, then climbed by 29.3% to $189.1 million in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $189.1 million, $154.5 million, and $146.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.